trending Market Intelligence /marketintelligence/en/news-insights/trending/omfatf3fei2ssnjmd23ujq2 content esgSubNav
In This List

Petlife Pharmaceuticals CEO resigns; replacement named

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Petlife Pharmaceuticals CEO resigns; replacement named

Petlife Pharmaceuticals Inc. appointed Laura De Leon Castro as president, CEO, secretary, treasurer, CFO and board chairman after the resignation of Ralph Salvagno, effective March 22.

Salvagno's resignation was not the result of any disagreements with the company regarding its operations, policies, practices or otherwise, according to the company.

Castro has previously served as the assistant to the CEO of Gatorade Mexico from 2001 to 2003.

In addition, Vyvyan Campbell resigned as director of Petlife Pharmaceuticals, also effective March 22.

Petlife said Campbell's resignation was not the result of any disagreements with the company regarding operations, policies, practices or otherwise.

Hancock, Md.-based Petlife Pharmaceuticals engages in the research, development, sale, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases in the U.S.